(S)-2-(3-(2-(3,4-dimethoxyphenyl)acetyl)guanidino)-N-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-3-phenylpropanamide

ID: ALA3321924

Chembl Id: CHEMBL3321924

PubChem CID: 90285921

Max Phase: Preclinical

Molecular Formula: C30H31N5O6

Molecular Weight: 557.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CC(=O)NC(=N)N[C@@H](Cc2ccccc2)C(=O)NCCN2C(=O)c3ccccc3C2=O)cc1OC

Standard InChI:  InChI=1S/C30H31N5O6/c1-40-24-13-12-20(17-25(24)41-2)18-26(36)34-30(31)33-23(16-19-8-4-3-5-9-19)27(37)32-14-15-35-28(38)21-10-6-7-11-22(21)29(35)39/h3-13,17,23H,14-16,18H2,1-2H3,(H,32,37)(H3,31,33,34,36)/t23-/m0/s1

Standard InChI Key:  ZVHZJFRBDYJHEP-QHCPKHFHSA-N

Associated Targets(Human)

REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSD Tchem Cathepsin D (3201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CTSD Cathepsin D (510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 557.61Molecular Weight (Monoisotopic): 557.2274AlogP: 1.91#Rotatable Bonds: 11
Polar Surface Area: 149.92Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.37CX Basic pKa: 8.08CX LogP: 2.36CX LogD: 1.60
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.16Np Likeness Score: -0.60

References

1. Grädler U, Czodrowski P, Tsaklakidis C, Klein M, Werkmann D, Lindemann S, Maskos K, Leuthner B..  (2014)  Structure-based optimization of non-peptidic Cathepsin D inhibitors.,  24  (17): [PMID:25086681] [10.1016/j.bmcl.2014.07.054]

Source